22.79MMarket Cap
LossP/E TTM
Barinthus Biotherapeutics PLC
BRNS Balance Sheet
You can check out the annual or quarterly balance sheets of Barinthus Biotherapeutics PLC here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing BRNS stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Barinthus Biotherapeutics PLC Have?
In its most recent quarterly, Barinthus Biotherapeutics PLC had 65.86M in cash and cash equivalents.
How Much Are Barinthus Biotherapeutics PLC's Total Liabilities?
Barinthus Biotherapeutics PLC reported 23.88M in total liabilities as of the latest reported quarter, including 10.02M in current liabilities and 13.86M in non-current liabilities.
What Are Barinthus Biotherapeutics PLC's Total Assets?
As of the latest reported quarter, Barinthus Biotherapeutics PLC's total assets were 98.17M, consisting of 77.79M in current assets and 20.38M in non-current assets.
How Much Shareholders' Equity Does Barinthus Biotherapeutics PLC Have?
Barinthus Biotherapeutics PLC reported 74.29M in total shareholders' equity as of the latest reported quarter.